Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement-Reference-Cited by-同舟云学术

Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement

Published:2013-10-14 Issue:6 Volume:16 Page:724-730
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Yahya Fariz¹,Jasmin Raja¹,Ng Chin Teck¹,Cheah Tien Eang¹,Sockalingam Sargunan¹

Affiliation:

1. Division of Rheumatology; Department of Medicine; Faculty of Medicine; University of Malaya; Kuala Lumpur Malaysia

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12179/fullpdf

Reference9 articles.

1. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies;Bandelier;Swiss Med Wkly,2009

2. Pharmacological therapy of lupus nephritis;Fine;JAMA,2005

3. Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial;Gaubitz;Lupus,1999

4. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation;Fulton;Drugs,1996

5. Enteric-coated mycophenolate sodium for transplant immunosuppression;Ingle;Am J Health Syst Pharm,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic glucocorticoid therapy for SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity;Clinical Reviews in Allergy & Immunology;2023-06-20

3. Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond;International Journal of Rheumatology;2021-05-18

4. Interventions for cutaneous disease in systemic lupus erythematosus;Cochrane Database of Systematic Reviews;2021-03-09

5. AB0530 THE EFFECT OF MYCOPHENOLATE MOFETIL ON NON-RENAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS FROM 2014 TO 2018: OBSERVATION STUDY FROM KOREAN LUPUS NETWORK (KORNET) REGISTRY;Abstracts Accepted for Publication;2019-06